Trade AARD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Aardvark Therapeutics, Inc. (AARD) is trading at US$1.59, up 16.06% today as of Nov 11, 16:00 EST. The company has a market capitalisation of US$149.25M. Over the past 52 weeks, AARD has traded between US$0.93 and US$16.60. On Syfe you can trade AARD with $0 commission and add it to your watchlist.
| Previous close | US$1.37 |
|---|---|
| Market cap | US$149.25M |
| 52-week range | US$0.93 – US$16.60 |
| Volume | 387.19K |
| Exchange | US |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Year: 2025
Aardvark Therapeutics, Inc. (AARD) stock is trading at US$1.59, +16.06% from the previous close of US$1.37.
The market cap for Aardvark Therapeutics, Inc. (AARD) stock is approximately US$149.25M.
The 52-week high for Aardvark Therapeutics, Inc. (AARD) stock is US$16.60.
The 52-week low for Aardvark Therapeutics, Inc. (AARD) stock is US$0.93.
Aardvark Therapeutics, Inc. (AARD) does not currently pay a dividend.
Stay on top of AARD
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
